beta-Amyrin acetate has a higher antioxidant potential with an IC50 value of 158.2ug/mL, and has cytotoxicity , it could be a viable source of antioxidant and cytotoxic agents in cancer chemotherapy in the near future.[1]
beta-Amyrin acetate and beta-Amyrin palmitate are anti-dyslipidemic agents from Wrightia tomentosa leaves.[2]
beta-Amyrin acetate has anti-inflammatory activity,with ID50 values in the range of 0.15-0.75 micromol/ear.[3]
beta-Amyrin acetate exhibits weak-moderate antiproliferative activity against the A2780 human ovarian cancer cell line. [4]
English website: beta-Amyrin acetate
Japanese website: beta-Amyrin acetate
Chinese website: beta-Amyrin acetate
[1] Fabiyi O A, Atolani O, Adeyemi O S, et al. Asian Pac J Trop Biomed, 2012, 2(2):S981–S4.
[2] Ranjani Maurya, Anuj Srivastava, Priyanka Shah,et al. Phytomedicine: International Journal of Phytotherapy & Phytopharmacology, 2012,19(8-9):682.
[3] Akihisa T, Kojima N, Kikuchi T, et al. J Oleo Sci, 2010, 59(6):273-80.
[4] Topçu G, Yapar G, Türkmen Z, et al. Phytochem Lett, 2011, 4(4):421-5.
[5] S Xiong, Ding CJ, Lee Z, et al. J Pharm Anal, 2010 (01): 21-3.
